Short answer
Sanara MedTech Inc. (SMTI) filed an 8-K current report with the SEC on June 4, 2026 reporting Item 1.02 (Termination of a Material Definitive Agreement). Services Agreement with Catalyst terminated effective June 2, 2026.
Sanara MedTech Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.02 · Termination of a Material Definitive Agreement
- Services Agreement with Catalyst terminated effective June 2, 2026
- Termination reflects strategic shift toward soft tissue repair and bone fusion products
- No termination fee or penalty paid, limiting immediate financial impact
- Catalyst remains subject to indemnification and confidentiality obligations
- Related-party governance relevance: Chairman Ronald T. Nixon founded Catalyst, whose affiliates own more than 5% of SMTI shares
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Sanara MedTech Inc. 8-K filings
Get the next SMTI 8-K as it lands
Follow SMTI for push alerts, or ask the research agent what this filing means.